The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population - Concepedia

Concepedia

Publication | Open Access

The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population

DOI Full Paper Access

67

Citations

15

References

2017

Year

Leonardo A. Martínez, Elena Larrieta‐Carrasco, Juan J. Calva, David Kershenobich, Aldo Torre

Annals of Hepatology

Abstract

PNPLA3 expression in Hispanics could be decisive in NAFLD pathogenesis, it's highly prevalent and it's a key to condition and determine the spectrum associated, SS, NASH and fibrosis.

References

	Year	Citations
Harmonizing the Metabolic Syndrome K. G. M. M. Alberti, Robert H. Eckel, Scott M. Grundy, Circulation ObesityMetabolic SyndromeBody CompositionMetabolic DisorderCardiovascular Disease	2009	14.3K
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆ Christi A Matteoni, Zobair M. Younossi, T GRAMLICH, Gastroenterology ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisHepatic DisordersHepatology	1999	3.4K
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Stefano Romeo, Julia Kozlitina, Chao Xing, Nature Genetics Metabolic SyndromeHepatologyGeneticsLiver PhysiologyGenetic Epidemiology	2008	3.3K
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome Giulio Marchesini, Elisabetta Bugianesi, Gabriele Forlani, Hepatology	2003	2.7K
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Gastroenterology ObesityMetabolic SyndromePractice GuidelineMetabolic Associated SteatohepatitisHepatology	2012	1.8K
The Natural History of Nonalcoholic Steatohepatitis: A Follow–Up Study of Forty–Two Patients for Up to 21 Years Elizabeth E. Powell, Graham Cooksley, Reginald G. Hanson, Hepatology	1990	1.5K
Endpoints and clinical trial design for nonalcoholic steatohepatitis Arun J. Sanyal, Elizabeth M. Brunt, David E. Kleiner, Hepatology	2011	749
The Role of Ultrasound in the Diagnosis of Hepatic Steatosis in Morbidly Obese Patients Cláudio Corá Mottin, Myriam Moretto, Alexandre Vontobel Padoin, Obesity Surgery ObesityMedical UltrasoundHepatologyLiver PhysiologyAbdominal Imaging	2004	303
Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity Carmelo García‐Monzón, Elena Martín‐Pérez, Oreste Lo Iacono, Journal of Hepatology ObesityMetabolic SyndromeInflammationMetabolic Associated SteatohepatitisPrognostic Factors	2000	265
Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome? Giovanni Musso, Roberto Gambino, Simona Bo, Diabetes Care	2008	198

Page 1